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Abstract
Among more than 2050 brains in our Alzheimer disease brain banks we came across three brains
with well demarcated indurated white-yellow nodules in the amygdalas. Microscopically, these
nodules were composed of numerous lipid-laden macrophages located in the central region
surrounded by an eosinophilic hyaline-like material with minimal reactive gliosis in the periphery.
Neurons within these lesions had a normal appearance but were moderately decreased in number.
Beta-amyloid, tau and alpha-synuclein immunostaining revealed no abnormal deposits within the
nodules. The three patients had long histories of dementia (one linked to a presenilin-1 mutation).
The neuropathological diagnoses were Alzheimer disease in two of them and an unclassified
tauopathy with argyrophilic grains in the third.
Conclusion—The pathogenesis of these lesions is uncertain. We favor that the degeneration has
some relationship to the underlying dementing disease, either secondary to deafferentation or an
alteration in metabolic demand, perhaps related to the bi-directional anatomical and functional
connections that exist between the amygdala and the hippocampus or less likely as a primary
event.
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Introduction
The amygdala is a component of the limbic system that has a modulatory effect on the
acquisition and consolidation of memories that evoke an emotional response [3,4]. In
humans, selective amygdala lesions have only rarely been reported. Bilateral amygdaloid
lesions are a typical feature of Lipoid Proteinosis or Urbach-Wiethe disease, a rare
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autosomal recessive genodermatosis due to mutations in the extracellular matrix protein 1
(ECM1) gene [7]. Among more than 2050 brains in our Alzheimer Disease Research Center
brain banks we came across three brains with well demarcated unusual nodular lesions in the
amygdalas from two patients with Alzheimer disease and one with an unclassifiable
tauopathy and no evidence of other underlying disease. In two of the brains the nodules were
recorded as bilateral. Curiously, all three patients came to autopsy in the two Centers within
an 18 month period.
Patients
Patient 1 was a woman, with no family history of dementia or other neurological diseases,
who died aged 50 years after a ten-year period of intellectual decline progressing to
profound dementia. She had a history of depression beginning in her twenties.
Approximately 10 years prior to death she was fired as a data analyst because of mistakes
due to memory problems and possible paranoid delusions. She became a grocery store
bagger but frequently forgot to pick up her paycheck. Five years prior to death she moved
into her mother's house because she could no longer manage her affairs. The same year she
made several suicide attempts and was hospitalized. On examination, she was alert and
oriented with 0/3 memory at zero and five minutes and was unable to subtract serial sevens.
All laboratory tests were within normal range. Magnetic resonance imaging (MRI) of the
brain revealed mild to moderate atrophy. She was started on Prozac. A year later she began
to lose her way driving familiar routes. Other mental status evaluations over the next two
years revealed severe recent memory deficits but intact long term memory and 'normal
higher function'. She was started on Aricept and Zoloft but her memory continued to
deteriorate and she increasingly accused others of stealing from her. She was eventually
placed in a nursing home 18 months prior to her death. Her mother was alive and well aged
78. Her father died of esophageal carcinoma aged 71. She had no family history of
neurological disease. Over the last months of her life she lost the ability to use a knife and
fork, her speech output diminished to just a few words and she needed a feeding tube. There
was no history of seizures.
Patient 2 was a woman who died aged 87 years who presented to the Memory Disorders
Clinic 13 years prior to her death with declining memory and personality changes for the
previous two years and a remote right cerebellar infarct. She had a Blessed Dementia Scale
score of 9 and a Hachinski Ischemia Scale score of 8. She had no family history of dementia.
She progressively lost her ability to perform the activities of daily living and was placed in a
nursing home 9 years prior to her death. She was last evaluated 4 years prior to death at
which time her Blessed Dementia Scale score was 25 and she had mild dystonia, shuffling
gait and '4+ en bloc' turning.
Patient 3 was a man who died aged 46 years following an eleven-year period of progressive
cognitive decline beginning with memory difficulties and depression at the age of 35 years.
His only evaluation in the Cognitive Disorders Program at the University of Michigan took
place about one month before his death. At this time he was severely demented, wheelchair
bound and living in a nursing home. He was unable to cooperate with testing but was awake
and alert. He used few words but tended to curse. He had gait ataxia, 3+ rigidity, without
cogwheel rigidity, occasional myoclonic jerks and diffuse symmetric hyperreflexia. MRI
revealed diffuse atrophy. His mother died aged 42 with a post-mortem diagnosis of
Alzheimer disease. A half-brother died at the age of 42 with severe dementia. Another two
full siblings and three full siblings were alive and well. A presenilin 1 mutation was found.
He died a month later.
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All autopsies were limited to examination of the brain and were performed according to the
protocols of our Alzheimer Disease Research Centers [22]. Briefly, the cerebral hemispheres
were divided in the sagittal plane and one hemisphere was coronally sectioned in the fresh
state and the slices flash frozen and stored in a −80° C freezer. The other half was fixed in
formalin for one to two weeks and then sectioned in the coronal plane on standardized
landmarks. Paraffin sections from standardized areas were stained according to the protocol
outlined in Vonsattel et al [22] including Luxol fast blue/ hematoxylin and eosin (LHE),
modified Bielschowsky, beta amyloid, tau and alpha synuclein. Additional stains performed
on the amygdala nodules included trichrome, phosphotungstic acid hematoxylin (PTAH),
Congo red, PAS, reticulin, von Kossa (for calcium), Grocott’s methenamine silver, and
hematoxylin and eosin and immunohistochemical stains for CD68, GFAP, CD45, Neu N
and neurofilament. Samples of the formalin fixed amygdala nodules were dissected from the
8 and 9 year formalin fixed tissue (cases 1 and 2), post fixed in glutaraldehyde and examined
with the electron microscope. Photographs of the fresh and fixed slices were available for
patients one and two. CERAD scores [13] were estimated as outlined by Vonsattel et al. [22]
and NIA Reagan scores of neurofibrillary degeneration were estimated as described in
Newell et al. [14].
Patient 1: The brain weighed 992 grams and had marked frontal and temporal lobe atrophy.
Both amygdalas were moderately atrophic. The anterior aspects of both amygdalas
contained multiple yellow nodular indurated lesions ranging from 0.1 to 1.5 cm in greatest
diameter (Figure 1a). X-rays of the slices showed no calcification. The hippocampi were
severely atrophic with numerous plaques and neurofibrillary tangles (NFT) but no ischemic
type changes. Numerous NFT and plaques were present in all areas of the cortex. The
pathological diagnosis was severe Alzheimer disease, Braak and Braak stage VI and definite
AD by CERAD criteria.
Patient 2: The brain weighed 1010 grams and had mild frontal, parietal and temporal lobe
atrophy and enlarged lateral ventricles (19 ml on left, normal 5–7 ml). The substantia nigra
was pale and the hippocampus was mildly atrophic. Both amygdalas had central 0.7 cm
areas of white discoloration (Figure 1b). Microscopic exam showed rare NFT in frontal,
temporal and cingulate gyri and large numbers in the entorhinal cortex and amygdala. Tau
immunostain revealed that most of these tangles were perinuclear. There were no diffuse or
neuritic plaques in the cortex or hippocampus. The hippocampus was well preserved with
scattered more conventional NFT as well as pretangles, and silver and ubiquitin positive
granules in the neuropil. Several hippocampal neurons contained ubiquitin positive nucleolar
sized intranuclear inclusions and occasional faint tau positive cytoplasmic inclusions, but no
diffuse or neuritic amyloid plaques. The pathological diagnosis was an unclassified
tauopathy, not fitting into most of the defined tauopathies, with argyrophilic grains. There
were two small old infarcts in the basal ganglia. The larger was 1.0 cm in greatest
dimension.
Patient 3: The brain weighed 1120 grams and had moderate diffuse atrophy of all lobes with
moderate to marked dilatation of the lateral ventricles, particularly the temporal horns.
Microscopically numerous NFT were present in the hippocampus, parahippocampal gyrus
and amygdala as well as moderate numbers in the occipital and insular cortex (Braak and
Braak Stage VI), thus fulfilling the NIA-Reagan criteria for a ‘High Likelihood’ that the
dementia was due to Alzheimer disease and the CERAD criteria for Definite Alzheimer
Disease. The gross appearance of the amygdalas was not commented upon but more than
one section was taken from it implying that an abnormality was recognized at the time of the
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gross examination. The method of freezing precluded obtaining useful information about the
other amygdala in this case.
Amygdala Lesions
The nodules in all three brains were mainly located in the basolateral nuclear group of the
amygdala while the remaining amygdala nuclei were preserved. The microscopic
characteristics of all three cases were similar. They consisted of sharply defined
paucicelllular areas within the amygdala with numerous foamy lipid-laden cells in their
centers (Figure 2a–i), surrounded by eosinophilic hyaline-like material with minimal
reactive gliosis at the periphery (Figure 2b,e,f,h). Some of the foamy cells contained luxol
fast blue positive material and most of them were positive for CD68 (Figure 2c,e,i). The few
remaining neurons within these lesions appeared normal (Figure 2e,f,i and Figure 3). No
calcium accumulation was demonstrated. Trichrome and PTAH stains confirmed the lack of
collagen (Figure 3b). The hyaline material did not stain for Congo Red or react with beta
amyloid. CD-68 confirmed that most of the foamy cells were macrophages (Figure 2c).
CD45 revealed scattered mononuclear cells and microglia both in and around the nodules.
NeuN illustrated the presence of viable neurons (Figure 2i). GFAP and PTAH confirmed
minimal reactive astrocytosis at the periphery (Figure 3b and d). Bielschowsky silver and
neurofilament antibody revealed relatively spared axons and occasional axonal spheroids
(Figure 3c and inset) at the periphery as well as neurofibrillary tangles in the surrounding
amygdala (Figure 3a). No Congo red, beta-amyloid, tau or alpha-synuclein deposits were
found within the lesions. Electron microscopy of tissue retrieved after 8 years in formalin
from case 1 revealed vascular basal lamina thickening but no other specific alterations. Case
2 had markedly thickened small blood vessel walls in the amygdalas as well as in other areas
of the brain consistent with hypertensive arteriosclerotic changes (Figure 2f).
Discussion
We present three cases with striking and selective amygdala damage found among more
than 2050 brains in our Alzheimer disease brain banks. The pathogenesis of these lesions is
uncertain.
One possible etiology considered was ischemia. Among the amygdaloid nuclei, the
basolateral nuclear group (lateral, laterobasal, accessory basal and mediobasal nuclei) is the
most likely to suffer from ischemic changes but these lesions are usually associated with
damage in the hippocampus [20]. In our cases the hippocampus and entorhinal cortex had no
evidence of ischemic changes and there were no other histological signs of ischemia within
the amygdala lesions. The possibility that these lesions are remnants of bilateral infarcts in
the territory of the anterior choroidal arteries or in the proximal branches of the middle
cerebral arteries seems highly unlikely since in at least two of the cases the lesions are
bilateral and no damage in other areas of these vascular territories was present. In addition,
neurons within them are intact although there are a large number of macrophages in the
center of the lesions.
Bilateral amygdaloid lesions are a typical feature of Lipoid Proteinosis or Urbach-Wiethe
disease, a rare autosomal recessive genodermatosis due to mutations in the extracellular
matrix protein 1 (ECM1) gene [7]. Lipoid proteinosis is characterized by multisystem
involvement with intracellular deposition of amorphous hyaline material. Our patients had
no skin abnormalities described clinically or recognized at the time of autopsy. None of
them had the bilateral amygdala calcifications that are characteristic of this syndrome.
Microscopic findings of Lipoid Proteinosis in brain [11] include gross amorphous
calcification encompassed by gliotic tissue and calcified thickened vessels walls.
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The possibility of parenchymal amyloidomas was ruled out by lack of Congo red and beta-
amyloid staining and by electron microscopy. Histologically, the lesions have a resemblance
to some of the abnormalities found in Wernicke encephalopathy, but although the neurons
were mostly spared, the vasculature was not prominent and the typical locations affected in
this disease were normal.
Epilepsy, especially status epilepticus, can also affect the amygdala resulting in histological
similarities to those found in diffuse ischemia [1,12] but in most of those patients the
changes have been accompanied by profound damage to the hippocampus and other areas of
the cortex [12]. The patients that we report do not have a history of epilepsy, the
hippocampus is well preserved and the amygdalas did not show a significant neuronal loss
or major reactive gliosis. Other entities that could affect selectively the amygdala and the
rest of the limbic system bilaterally are herpes simplex [3] and paraneoplastic encephalitis
[5] but the very well defined lesions, the absence of inflammation, neuronophagia or
significant neuronal loss make these etiologies very unlikely.
Can the amygdala lesions be related to the underlying dementing diseases? Could the
damage be a result of alterations in the bi-directional anatomical or functional connections
between the amygdala and the hippocampus [6,15,16,19], either as a result of
deafferentation or metabolic demand? This possibility is supported by previous studies that
demonstrated significant anomalies in the amygdala in patients with AD [9,10]. Amygdaloid
atrophy and neuronal loss are more prominent in the basolateral nuclear group, especially in
patients with long lasting dementia [17,20]. In our patients, the basolateral nuclear group
was also almost selectively affected, but analogous macroscopic or microscopic findings to
these three cases have not been previously reported in any neurodegenerative disease. The
major hippocampal connections reciprocally link the basolateral group with the entorhinal
cortex, subiculum and the ammonic hippocampal regions [15,16]. Theories of anterograde
and retrograde degenerative processes support the suggestion of a “spreading” mechanism
via well-defined sets of connecting fibers [8]. Another possible explanation for this
distribution pattern might be neurochemical differences in the subdivisions of the amygdala,
with the basolateral group having a richer cholinergic innervation [2,10].
Unfortunately our patients were too demented for testing of amygdala function but there is
no evidence in the medical records of any of the typically described symptoms associated
with amygdala damage, such as impairment of emotions linked to facial expression,
alteration in memories with an emotional component [18], loss of precautionary behavior or
monetary loss aversion [4]. Patients with bilateral amygdala damage show cognitively little
deviation from normal subjects [18] therefore it is very unlikely that these amygdala lesions
played a role in the dementia symptoms in our patients
In summary, we report unusual degeneration of the amygdalas of unknown etiology in three
patients with long-standing dementia due to different pathophysiologies. The connection
between these lesions and these patients’ illnesses is obscure.
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Coronal sections of the brains at the level of the infundibulum. Note the well demarcated
white-yellow nodules mainly located in the basolateral nuclear group of the amygdalas. (a:
unfixed brain of patient 1. b: formalin fixed brain of patient 2)
Lain et al. Page 7














The nodules are sharply defined and composed of numerous lipid-laden macrophages
located in a central region (a–i) surrounded by an eosinophilic hyaline-like material (b,e,h).
CD68 stain reveals numerous positive macrophages (c). Neurons within these lesions
appeared normal but were moderately decreased in number. (e,f,i and e inset). In i, the
normal amygdala is on the right and the macrophage filled center is on the left of the figure.
Thick walled blood vessels can be seen in e and f. Case 1 (a–c), Case 2 (d–f) and case 3 (g–
i). a and d: Bielschowsky silver; b,e–h LHE stain; c: CD68 immunostain; i: NeuN
immunostain. Original magnifications: a,b,c,e,f,g,i 100x; c inset 200x; d, whole mount; h:
200x)
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Neurofibrillary tangles are present around the margin of the nodule in case 1 (a). Glial fibrils
are present but no collagen in case 3 (b). Intact neurons can be found within the lesions (c,
case 2). Inset c shows an axonal spheroid at the edge of the nodule in case 1. Gliosis forms
part of the rims of the nodules (d). Tau stained dystrophic neurites at the edge of edge of the
nodule (e, case 1) Note the foamy cells in the upper right. Some neuritic plaques remain
within the nodules (f, case 1). a and e: immunostain for tau; b: PTAH stain; c: immunostain
for neurofilament; d: immunostain for GFAP; f and inset c: Bielschowsky silver. Original
magnifications: a and d 100x; b 400x; c,e,f 200x
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